Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

MBX Biosciences (MBX) Cash from Financing Activities (2023 - 2026)

MBX Biosciences has reported Cash from Financing Activities over the past 4 years, most recently at $87.4 million for Q1 2026.

  • Quarterly results put Cash from Financing Activities at $87.4 million for Q1 2026, up 2185775.0% from a year ago — trailing twelve months through Mar 2026 was $277.0 million (up 18.42% YoY), and the annual figure for FY2025 was $189.6 million, down 19.01%.
  • Cash from Financing Activities reached $87.4 million in Q1 2026 per MBX's latest filing, up from $438000.0 in the prior quarter.
  • Across five years, Cash from Financing Activities topped out at $235.8 million in Q3 2024 and bottomed at -$1.8 million in Q2 2024.
  • Median Cash from Financing Activities over the past 4 years was $310500.0 (2024), compared with a mean of $51.1 million.
  • The largest annual shift saw Cash from Financing Activities crashed 794.74% in 2024 before it surged 2185775.0% in 2026.
  • Over 4 years, Cash from Financing Activities stood at $19000.0 in 2023, then plummeted by 794.74% to -$132000.0 in 2024, then skyrocketed by 431.82% to $438000.0 in 2025, then soared by 19862.33% to $87.4 million in 2026.
  • Business Quant data shows Cash from Financing Activities for MBX at $87.4 million in Q1 2026, $438000.0 in Q4 2025, and $187.8 million in Q3 2025.